Infectious Dis. Medical News about Papillomavirus Vaccines Gardasil

Your Unread Messages

See All

Hello, Mary O'connor
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

ACIP Supports 'Permissive Use,' But Not Routine Use, of Gardasil in Males
American Family Physician, 10/29/09

Mitchell D – The CDC's Advisory Committee on Immunization Practices, or ACIP, has recommended against the routine use of quadrivalent human papillomavirus, or HPV, vaccine to prevent genital warts in boys and young men. Instead, the committee voted during its Oct. 21–22 meeting in Atlanta to support the "permissive use" of Gardasil, Merck & Co. Inc.'s quadrivalent HPV vaccine, leaving decisions on whether to immunize males ages 9–26 years who request the vaccine up to their health care professionals. However, the committee did recommend that the CDC provide funding for administration of the vaccine through the agency's Vaccines for Children, or VFC, program for males who want to receive it. Gardasil has not been shown to prevent cancer in males, and some ACIP members at the meeting viewed warts primarily as a cosmetic or fairly benign problem that – except in some rare instances – was less serious than other vaccine–preventable diseases.

<< Previous
The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation...

Next >>
Antibiotic Use in Neonatal Intensive Care Units and Adherence...

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09 Relevance Score: 83%

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09 Relevance Score: 81%

U.S. OKs Merck shot to prevent male genital warts
Reuters, 10/19/09 Relevance Score: 80%

New HPV Vaccine Might Stop Vulvar Cancer in Its Tracks
MedLinePlus, 11/06/09 Relevance Score: 79%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09 Relevance Score: 70%